Business plan & valuation

Drugs2Market can support in building of assessing of business plans for product launch or relaunch. Our experts can support to shape, help to focus or critically assess valuations proposed by teams on strategic direction.

Drugs2Market can quantify revenue targets, assess required capital investments (CAPEX) and operating costs (OPEX), evaluate funding needs, and structure all assumptions within a comprehensive business plan supported by a timeline and key milestones.